[TNGX] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[TNGX] Tango Therapeutics, Inc.
Announcement Date
11-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- -13.57%
YoY- -106.81%
Quarter Report
TNGX's Result
TNGX's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 6,411 6,920 5,771 5,758 5,716 6,787 18,153 -49.94%
PBT -29,009 -29,050 -24,855 -25,208 -21,869 -19,528 -4,514 244.48%
Tax 51 -873 3 -171 177 62 -21 -
NP -29,060 -28,177 -24,858 -25,037 -22,046 -19,590 -4,493 245.96%
Tax Rate - - - - - - - -
Total Cost 35,471 35,097 30,629 30,795 27,762 26,377 22,646 34.76%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -453.28 -407.18 -430.74 -434.82 -385.69 -288.64 -24.75 591.13%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.33 -0.32 -0.28 -0.29 -0.25 -0.28 -0.05 250.64%
EPS Diluted -0.33 -0.32 -0.28 -0.29 -0.25 -0.28 -0.05 250.64%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.